Page
%P
-
Article
Risk factors for bone pain among patients with cancer receiving myelosuppressive chemotherapy and pegfilgrastim
The purpose of this study was to evaluate risk factors for bone pain in patients receiving myelosuppressive chemotherapy and pegfilgrastim.
-
Article
Open AccessAutoimmunity against p53 predicts invasive cancer with poor survival in patients with an ovarian mass
Serum autoantibodies against the p53 protein (p53 AAb) were analysed with a newly developed enzyme-linked immunosorbent assay (ELISA) based on highly purified and renatured p53. In a hospital-based cohort stud...
-
Article
Open AccessSerum p53 autoantibodies in patients with minimal lesions of ductal carcinoma in situ of the breast
Five of 43 patients (11.6%) with ductal carcinoma in situ of the breast presented with p53 autoantibodies at diagnosis. Three seropositive patients demonstrated tumour sizes of ≤ 5 mm. There was no association...
